Atlas Trials

Capecitabine Versus Bolus 5-Fu Associated to Radiotherapy as Neoadjuvant Treatment for Rectal Cancer.

Clinical trial NCT03428529 · COMPLETED

Trial details

NCT number
NCT03428529
Sponsor
Instituto Nacional de Cancer, Brazil
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Rectal Neoplasm Malignant
Start date
2011-01-12
Primary completion
2016-10-13
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.